Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study

Autor: Barrachina J, Margarit C, Muriel J, López-Gil S, López-Gil V, Vara-González A, Planelles B, Inda MD, Morales D, Peiró AM

Publikováno v: SCIENTIFIC REPORTS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

Tapentadol (TAP) and oxycodone/naloxone (OXN) potentially offer an improved opioid tolerability. However, real-world studies in chronic non-cancer pain (CNCP) remain scarce. Our aim was to compare effectiveness and security in daily pain practice, to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4c90f13fe7f0136c169e2d9ba343787e
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9035

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study.

Autor: Barrachina J; Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c/Pintor Baeza, 12, 03010 Alicante, Spain., Margarit C; Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c/Pintor Baeza, 12, 03010 Alicante, Spain.; Pain Unit, Department of Health of Alicante-General Hospital, c/Pintor Baeza, 12, 03010 Alicante, Spain., Muriel J; Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c/Pintor Baeza, 12, 03010 Alicante, Spain.; Pain Unit, Department of Health of Alicante-General Hospital, c/Pintor Baeza, 12, 03010 Alicante, Spain., López-Gil V; Occupational Observatory, Miguel Hernández University of Elche, Avda. de la Universidad s/n, 03202 Elche, Spain., López-Gil S; Occupational Observatory, Miguel Hernández University of Elche, Avda. de la Universidad s/n, 03202 Elche, Spain., Ballester P; Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c/Pintor Baeza, 12, 03010 Alicante, Spain., Mira-Lorente L; Occupational Observatory, Miguel Hernández University of Elche, Avda. de la Universidad s/n, 03202 Elche, Spain., Agulló L; Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c/Pintor Baeza, 12, 03010 Alicante, Spain., Peiró AM; Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c/Pintor Baeza, 12, 03010 Alicante, Spain.; Department of Pharmacology, Paediatrics and Organic Chemistry, Miguel Hernández University of Elche, Crta. Nacional, N-332. s/n, 03505 Sant Joan, Spain.; Clinical Pharmacology Unit, Department of Health of Alicante-General Hospital, c/Pintor Baeza, 12, 03010 Alicante, Spain.

Publikováno v: Biomedicines [Biomedicines] 2022 Oct 02; Vol. 10 (10). Date of Electronic Publication: 2022 Oct 02.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.